Eyenuk, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Video & Media
Email & Communication
Keywords & Focus Areas
Eyenuk, Inc.
Overview
Eyenuk, Inc. is a global artificial intelligence digital health and medical technology company based in Los Angeles, California. Founded in 2010, it specializes in AI-driven eye screening for the early detection of various eye diseases and health risks, including diabetic retinopathy, glaucoma, age-related macular degeneration, and cardiovascular conditions.
The company's flagship product, the EyeArt AI Eye Screening System, is recognized for its autonomous technology that provides rapid screening results. EyeArt has been validated through extensive testing for high sensitivity and specificity in detecting vision-threatening conditions. It integrates seamlessly into clinical workflows, supporting both primary care and ophthalmic settings. With multiple regulatory approvals, including U.S. FDA clearance and CE marking in the EU, Eyenuk, Inc. operates as a Class IIb medical device provider, committed to expanding access to eye care globally through innovative solutions and partnerships.
Basic Information
| Industry | medical devices |
|---|---|
| Founded | 2010 |
| Revenue | $6M |
| Headquarters | 5850 Canoga Ave., Suite 250, Los Angeles, CA 91367, United States |
| Languages | English |
Contact Details
- Phone: +1 818-835-3585
- Website: eyenuk.com
- LinkedIn: linkedin.com/company/eyenuk-llc
Key Focus Areas & Initiatives
- Medical image analysis
- Consumer vision
- Ophthalmic medical devices
- Diabetic retinopathy
- Telemedicine
- Age related macular degeneration
- Retinal diseases
- Eye screening
- Macular degeneration
- Glaucoma
- Ophthalmology
- Optometry
- Optical
- Cataract
- Artificial intelligence
- Machine learning
- Diabetes
- Medical device
- Digital health
- Fundus imaging
- Predictive biomarkers
- AI diagnostics
- Vision loss prevention
- AI biomarkers
- Regulatory compliance
- B2B
- Retinal imaging
- Retinal cameras
- Real-world validation
- Healthcare automation
- Deep learning algorithms
- AI for health disparities
- Medical devices
- Risk assessment biomarkers
- Telemedicine integration
- Diabetic retinopathy detection
- Government
- Autonomous AI system
- Point-of-care screening
- AI for underserved populations
- AI in teleophthalmology
- Services
- AI for glaucoma screening
- Multi-camera AI detection
- AI for neurodegenerative diseases
- Early detection tools
- Medical equipment and supplies manufacturing
- Regulatory approvals
- Population health management
- AI healthcare solutions
- AI for age-related macular degeneration
- Clinical validation
- Retinal image analysis
- Disease screening
- AI lesion segmentation
- Healthcare technology
- Disease detection
- Image analysis algorithms
- AI eye screening
- AI-based disease surveillance
- FDA cleared AI
- AI in healthcare
- Digital health innovation
- Clinical trial validation
- AI-powered diagnostics
- AI for ophthalmology
- Medical AI
- AI in ophthalmology
- Healthcare
- Health care information technology
- Health care
- Health, wellness & fitness
- Hospital & health care
- Information technology & services
- Medical
Technologies Used
- AI
- Amazon AWS
- Amazon SES
- Apache
- Gmail
- Google Analytics
- Google Apps
- Google Font API
- Google Tag Manager
- Gravity Forms
- Microsoft Office 365
- Mobile Friendly
- Remote
- Salesforce
- Slack
- WordPress.org
- YouTube
- Zendesk
- reCAPTCHA
Community
